4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-20-136547
Options or other derivatives
- Chief Financial Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-20-136547
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…